Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 83

1.

Are all people with diabetes and cardiovascular risk factors or microvascular complications at very high risk? Findings from the Risk and Prevention Study.

Marzona I, Avanzini F, Lucisano G, Tettamanti M, Baviera M, Nicolucci A, Roncaglioni MC; Risk & Prevention Collaborative Group..

Acta Diabetol. 2016 Oct 7. [Epub ahead of print]

PMID:
27718051
2.
3.

[Prevention of Chronic Kidney Disease and strategies to counteract chronic diseases in Italy].

Mastrilli V, D'Elia R, Galeone D.

G Ital Nefrol. 2016 Jul-Aug;33(4). pii: gin/33.4.5. Italian.

PMID:
27545630
4.
5.

Delayed presence of alternatively activated macrophages during a Francisella tularensis infection.

D'Elia RV, Laws TR, Núñez A, Taylor C, Clark GC.

Microb Pathog. 2015 Jan;78:37-42. doi: 10.1016/j.micpath.2014.10.002.

PMID:
25284816
6.

Protection against experimental melioidosis following immunisation with a lipopolysaccharide-protein conjugate.

Scott AE, Ngugi SA, Laws TR, Corser D, Lonsdale CL, D'Elia RV, Titball RW, Williamson ED, Atkins TP, Prior JL.

J Immunol Res. 2014;2014:392170. doi: 10.1155/2014/392170.

7.

Targeting the "Rising DAMP" during a Francisella tularensis infection.

D'Elia RV, Laws TR, Carter A, Lukaszewski R, Clark GC.

Antimicrob Agents Chemother. 2013 Jun 24. [Epub ahead of print]

8.

Differential role for interleukin-6 during Francisella tularensis infection with virulent and vaccine strains.

Laws TR, Clark G, D'Elia RV.

Infect Immun. 2013 Aug;81(8):3055-6. doi: 10.1128/IAI.00234-13. No abstract available.

9.

Exploitation of bacterial N-linked glycosylation to develop a novel recombinant glycoconjugate vaccine against Francisella tularensis.

Cuccui J, Thomas RM, Moule MG, D'Elia RV, Laws TR, Mills DC, Williamson D, Atkins TP, Prior JL, Wren BW.

Open Biol. 2013 May 22;3(5):130002. doi: 10.1098/rsob.130002.

10.

Protection against experimental melioidosis following immunization with live Burkholderia thailandensis expressing a manno-heptose capsule.

Scott AE, Laws TR, D'Elia RV, Stokes MG, Nandi T, Williamson ED, Tan P, Prior JL, Atkins TP.

Clin Vaccine Immunol. 2013 Jul;20(7):1041-7. doi: 10.1128/CVI.00113-13.

11.

n-3 fatty acids in patients with multiple cardiovascular risk factors.

Risk and Prevention Study Collaborative Group..

N Engl J Med. 2013 May 9;368(19):1800-8. doi: 10.1056/NEJMoa1205409. Erratum in: N Engl J Med. 2013 May 30;368(22):2146.

12.

Targeting the "cytokine storm" for therapeutic benefit.

D'Elia RV, Harrison K, Oyston PC, Lukaszewski RA, Clark GC.

Clin Vaccine Immunol. 2013 Mar;20(3):319-27. doi: 10.1128/CVI.00636-12. Review.

13.

Brain magnetic resonance findings in symptomatic congenital cytomegalovirus infection.

Manara R, Balao L, Baracchini C, Drigo P, D'Elia R, Ruga EM.

Pediatr Radiol. 2011 Aug;41(8):962-70. doi: 10.1007/s00247-011-2120-5.

PMID:
21597906
14.

Inhibition of Francisella tularensis LVS infection of macrophages results in a reduced inflammatory response: evaluation of a therapeutic strategy for intracellular bacteria.

D'Elia R, Jenner DC, Laws TR, Stokes MG, Jackson MC, Essex-Lopresti AE, Atkins HS.

FEMS Immunol Med Microbiol. 2011 Aug;62(3):348-61. doi: 10.1111/j.1574-695X.2011.00817.x.

15.

A humanised murine monoclonal antibody with broad serogroup specificity protects mice from challenge with Venezuelan equine encephalitis virus.

Goodchild SA, O'Brien LM, Steven J, Muller MR, Lanning OJ, Logue CH, D'Elia RV, Phillpotts RJ, Perkins SD.

Antiviral Res. 2011 Apr;90(1):1-8. doi: 10.1016/j.antiviral.2011.01.010.

PMID:
21310183
17.

Invasive pneumococcal infections in infants up to three years of age: results of a longitudinal surveillance in North-East Italy.

Tardivo S, Poli A, Zerman T, D'Elia R, Chiamenti G, Torri E, Bonetti A, Pedevilla E, Pancheri P, Lubrano P, Savastano R, Meneghelli G, Romano G.

Ann Ig. 2009 Nov-Dec;21(6):619-28.

PMID:
20169833
18.

Expulsion of Trichuris muris is associated with increased expression of angiogenin 4 in the gut and increased acidity of mucins within the goblet cell.

D'Elia R, DeSchoolmeester ML, Zeef LA, Wright SH, Pemberton AD, Else KJ.

BMC Genomics. 2009 Oct 24;10:492. doi: 10.1186/1471-2164-10-492.

19.

In vitro antigen presenting cell-derived IL-10 and IL-6 correlate with Trichuris muris isolate-specific survival.

D'Elia R, Else KJ.

Parasite Immunol. 2009 Mar;31(3):123-31. doi: 10.1111/j.1365-3024.2008.01088.x.

20.

Regulatory T cells: a role in the control of helminth-driven intestinal pathology and worm survival.

D'Elia R, Behnke JM, Bradley JE, Else KJ.

J Immunol. 2009 Feb 15;182(4):2340-8. doi: 10.4049/jimmunol.0802767.

Items per page

Supplemental Content

Loading ...
Support Center